Butrans® (buprenorphine) Transdermal System CIII | Transdermal …
网页The buprenorphine in BUTRANS may increase the frequency of seizures in patients with seizure disorders, and may increase the risk of seizures in other clinical settings associated with seizures. Regularly evaluate patients with a history of seizure disorders for worsened seizure control during BUTRANS therapy.
Butrans® (buprenorphine) Transdermal System CIII | Patient …
网页Documentation and maintenance of careful prescribing and treatment records are essential, and should include: Physician and patient agreement. Proper assessment of the patient. Proper prescribing practices. Periodic reevaluation of therapy. Proper dispensing and correct storage and handling.
Butrans® (buprenorphine) Transdermal System CIII | How to Apply …
网页Serious, life-threatening, or fatal respiratory depression may occur with use of BUTRANS, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of BUTRANS are essential.
Butrans® (buprenorphine) Transdermal System CIII—Application …
网页Do not apply more than one patch at the same time unless your healthcare provider tells you to. Butrans carries a Boxed Warning and contains buprenorphine, a Schedule III controlled substance with an abuse potential similar to other Schedule III opioids.
网页Patch application site tracker example KEY PDU = Patch-Disposal Unit FF = Folding the Patch and Flushing it Down the Toilet Week L = Left R = Right